Type II phospholipase A2 in preterm human gestational tissues.

Area of Science:

• Obstetrics and Gynecology
• Reproductive Biology
• Inflammation Research

Background:

• Maternal genital tract infections and inflammation are linked to preterm labor.
• Type II phospholipase A2 (PLA2) hydrolyzes lipids, producing prostaglandins crucial for labor and inflammation.
• Understanding PLA2's role in preterm birth is vital for developing interventions.

Purpose of the Study:

• To quantify immunoreactive (ir) Type II PLA2 in placental, amniotic, and choriodecidual tissues from preterm and term deliveries.
• To compare ir Type II PLA2 levels between preterm and term deliveries, and in relation to labor status and membrane rupture.

Main Methods:

• Immune-reactive (ir) Type II PLA2 was quantified using ELISA in placental, amniotic, and choriodecidual tissues.
• Tissues were collected from women delivering preterm (n=26) and at term (n=42).
• Data were analyzed based on labor status (in labor vs. not in labor) and membrane status (ruptured vs. intact).

Main Results:

• Ir Type II PLA2 was significantly higher in preterm amnion and choriodecidua compared to term tissues.
• In preterm births, higher ir Type II PLA2 was found in the amnion of women not in labor versus those in labor.
• Spontaneous membrane rupture was associated with significantly greater ir Type II PLA2 in amnion and choriodecidua.

Conclusions:

• Type II PLA2 is elevated in placental tissues during preterm birth, particularly associated with spontaneous membrane rupture.
• These findings suggest a significant role for Type II PLA2 in the mechanisms leading to spontaneous preterm labor and membrane rupture.
• Further research into Type II PLA2 could lead to novel therapeutic targets for preventing preterm birth.